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LETTERS
Recent Shift in Age 
Pattern of Dengue 
Hemorrhagic Fever, 
Brazil
To the Editor: Brazil is responsi-
ble for >60% of reported cases of den-
gue fever (DF) in the American region 
(a designation of the Pan American 
Health Organization, which includes 
all of North, Central, and South Amer-
ica) (1). The epidemiologic character-
istics of dengue diseases in Brazil dif-
fer from those described in Southeast 
Asia. In Brazil, the incidence of DF 
and dengue hemorrhagic fever (DHF) 
is highest in adults. By contrast, in 
Southeast Asia, DHF cases predomi-
nate and occur more often in children 
than in adults (2,3). 
We describe a preliminary report 
of a shift in age group predominance 
that was observed during the 2007 
countrywide dengue epidemic in Bra-
zil. The Hospital Information System 
is the source of data describing the 
distribution of DHF cases from Janu-
ary 1998 through December 2007 (4). 
In Brazil almost all patients with a di-
agnosis of DHF are hospitalized. This 
country has promulgated the use of the 
World Health Organization’s DHF case 
deﬁ   nitions (International Classiﬁ  ca-
tion of Diseases, 10th revision – A91). 
In the 2007 epidemic, a larger than 
normal proportion of cases were DHF 
(2,706), more than twice the largest 
number of such cases reported in pre-
vious years. Moreover, in 2007 >53% 
of cases were in children <15 years of 
age; during 1998–2006, the predomi-
nance of DHF cases were in the 20- to 
40-year age group (online Appendix 
Figure, available from www.cdc.gov/
EID/content/14/10/1663-appF.htm). 
During 1998–2006, the percentage 
of DHF cases in children varied from 
9.5% (in 1998) to 22.6% (in 2001).
Of the 2,706 DHF cases in 2007, 
1,710 (63.2%) were reported from 
the northeast region; 1,119 (65.4%) 
of these were in children <15 years 
of age. The southeast region had the 
next largest number (558), accounting 
for 20.6% of all reported cases; how-
ever, only 26.2% were in children. 
Other regions with cases, central-west 
and northern, reported no substantial 
change in age distribution compared 
with earlier years. Among the 9 states 
in northeastern Brazil, DHF predomi-
nance in children was observed in 
Maranhao (609 cases; 92.0% in chil-
dren), Rio Grande do Norte (97 cases 
and 77.6%), Pernambuco (316 cases 
and 67.0%), and Ceara (197 cases and 
48.0%).
The change in age distribution of 
cases in 2007 is unique in the modern 
history of dengue in Brazil and re-
quires an explanation. Dengue 1 and 
2 viruses, which were introduced in 
the 1990s, generated epidemics of DF 
characterized by a low incidence of 
DHF, predominantly in adults. With 
the introduction of dengue 3 virus in 
2000–2001, DF epidemics of greater 
magnitude were observed, with a 
slightly larger fraction of DHF cases. 
Differences in the epidemiologic pat-
terns in Southeast Asia and the Ameri-
can region have been attributed to ge-
netic resistance in black populations 
and to underreporting of DHF cases, 
among other factors (2). These factors 
seem insufﬁ  cient to explain the sudden 
change observed; should it persist—as 
it has in Venezuela, Colombia, Cen-
tral America, and Cuba—this change 
may bring dengue in Brazil to a pat-
tern closer to that of Southeast Asia 
(2). This change in epidemiologic 
pattern of dengue cases supports calls 
for improvement in design of dengue 
surveillance studies to include, where 
possible, population-based serologic 
studies. These epidemiologic changes 
also serve as an alert to health authori-
ties in the American region to update 
their healthcare services to provide ag-
ile, opportune, and good quality care 
for patients, particularly children, with 
DHF, to reduce deaths.
Maria Gloria Teixeira, 
Maria Conceição N. Costa, 
Giovanini Coelho,
and Mauricio L. Barreto
Author afﬁ  liations: Federal University of Ba-
hia, Salvador, Bahia, Brazil (M.G. Teixeira, 
M.C.N. Costa, M.L. Barreto); and Ministry 
of Health, Brasilia, Brazil (G. Coelho)
DOI: 10.3201/eid1410.071164
References
  1.   Pan  American  Health  Organization. 
Number of reported cases of dengue & 
dengue hemorrhagic fever (DHF), re-
gion of the Americas 2000–2007. Wash-
ington: The Organization; 2001–2005 
[cited 2007 Sep 5]. Available from 
http://www.paho.org/common/Display.
asp?Lang=E&RecID=11173
  2.   Halstead SB. Dengue in the Americas and 
Southeast Asia: do they differ? Rev Pan-
am Salud Publica. 2006;20:407–15. DOI: 
10.1590/S1020-49892006001100007
    3.    Teixeira Mda G, Costa Mda C, Barreto 
ML, Mota E. Dengue and dengue hem-
orrhagic fever epidemics in Brazil: what 
research is needed based on trends, sur-
veillance, and control experiences? Cad 
Saude Publica. 2005;21:1307–15. DOI: 
10.1590/S0102-311X2005000500002
  4.   Ministério da Saúde. Sistema de informa-
ções hospitalares/SIH/SUS [cited 2008 
Mar 13]. Available from http://w3.datasus.
gov.br/siasih/siasih.php
Address for correspondence: Maria Gloria 
Teixeira, Instituto de Saude Coletive – 
Universidade Federal da Bahia, Rua Padre 
Feijo, 29 Canela, Salvador, Bahia 40.110-170, 
Brazil; email: magloria@ufba.br
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 14, No. 10, October 2008  1663 
Letters
Letters commenting on recent articles 
as well as letters reporting cases, out-
breaks, or original research are wel-
come. Letters commenting on articles 
should contain no more than 300 
words and 5 references; they are more 
likely to be published if submitted 
within 4 weeks of the original article’s 
publication. Letters reporting cases, 
outbreaks, or original research should 
contain no more than 800 words and 
10 references. They may have 1 Fig-
ure or Table and should not be divided 
into sections. All letters should con-
tain material not previously published 
and include a word count.